Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 66, Issue 19, Pages 13587-13606
Publisher
American Chemical Society (ACS)
Online
2023-09-28
DOI
10.1021/acs.jmedchem.3c00922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity
- (2023) Xiao-Meng Liu et al. Journal of Medicinal Chemistry
- Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction
- (2023) Qingwen Xiao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Novel Indole–Chalcone Derivative-Ligated Platinum(IV) Prodrugs Attenuate Cisplatin Resistance in Lung Cancer through ROS/ER Stress and Mitochondrial Dysfunction
- (2023) Zhikun Liu et al. Journal of Medicinal Chemistry
- A Clinically Translatable Ternary Platinum(IV) Prodrug for Synergistically Reversing Drug Resistance
- (2023) Ying Liu et al. Journal of Medicinal Chemistry
- Neoadjuvant therapy for pancreatic cancer
- (2023) Christoph Springfeld et al. Nature Reviews Clinical Oncology
- Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis
- (2022) Jingwei Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance
- (2022) Xinyi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A descriptive study on the treatment and outcomes of patients with platinum-sensitive, advanced, BRCA- or PALB2-related pancreatic cancer who have progressed on rucaparib.
- (2022) Timothy J Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells
- (2022) Yan Guo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N6-Methyladenosine Methylation
- (2022) Zheng-Yin Pan et al. Journal of Medicinal Chemistry
- Broadening horizons: the role of ferroptosis in cancer
- (2021) Xin Chen et al. Nature Reviews Clinical Oncology
- In Situ Supramolecular Self‐Assembly of Pt(IV) Prodrug to Conquer Cisplatin Resistance
- (2021) Qian Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells
- (2021) Meng Wang et al. BIOORGANIC CHEMISTRY
- Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
- (2021) Philipp Fronik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Conjugates Derived from Lapatinib Derivatives with Cancer Cell Stemness Inhibitors Effectively Reversed Drug Resistance in Triple-Negative Breast Cancer
- (2021) Yuanjiang Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance
- (2021) Yong Sun et al. Redox Biology
- Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
- (2021) Zuojie Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Frataxin as a regulator of ferroptosis
- (2020) Jing Du et al. Redox Biology
- Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo
- (2020) Xue-Qing Song et al. JOURNAL OF MEDICINAL CHEMISTRY
- xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
- (2020) Jinyun Liu et al. MOLECULAR THERAPY
- Ferroptosis: molecular mechanisms and health implications
- (2020) Daolin Tang et al. CELL RESEARCH
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
- (2019) Andrew E. Shouksmith et al. JOURNAL OF MEDICINAL CHEMISTRY
- P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma
- (2019) CHAO HE et al. ANTICANCER RESEARCH
- New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo
- (2019) Xue-Qing Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer
- (2019) Yuhong Sun et al. Cell Death & Disease
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- Platinum-Based Modification of Styrylbenzylsulfones as Multifunctional Antitumor Agents: Targeting the RAS/RAF Pathway, Enhancing Antitumor Activity, and Overcoming Multidrug Resistance
- (2019) Zhikun Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stimuli-Responsive Therapeutic Metallodrugs
- (2018) Xiaohui Wang et al. CHEMICAL REVIEWS
- A phase Ib/II pilot trial with nab-paclitaxel plus gemcitabine plus cisplatin in patients (pts) with stage IV pancreatic cancer.
- (2017) Gayle S. Jameson et al. JOURNAL OF CLINICAL ONCOLOGY
- Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery
- (2017) Jing Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pancreatic cancer: Tailored therapy for pancreatic tumour subtype
- (2017) Iain Dickson Nature Reviews Gastroenterology & Hepatology
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Discovery of New Monocarbonyl Ligustrazine–Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer
- (2016) Yong Ai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Role of the ROS/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells
- (2013) BO YI et al. Oncology Letters
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started